Loading...

CRBP CORBUS PHARMACEUTICALS HOLDINGS INC Management Changes 8-K Filing

CRBS

CRBP

CORBUS PHARMACEUTICALS HOLDINGS INC

(CRBP)

2025 8-K

Financial Updates

Investor Presentation Update

Director Resignation

Drug Study Results

Financial Results Update

Public Offering Announcement

Financial Update

Clinical Study Results

FDA Fast Track Approval

Financial Statements

Financial Statements

Management Change

Financial Results

Clinical Trial Update

Share Sale Plan

Financial Results

Stock Sale Plan

Presentation Update

Financial Results

Rule 10b5-1 Plan

Phase 1 Clinical Trial Data...

Equity Compensation Plan Ap...

Risk Factors Update

Financial Results

Amended Employment Agreements

Rule 10b5-1 Plans Adopted

Financial Results

Update on Investor Presenta...

Amendment Filing

Underwriting Agreement

Termination of Prospectus S...

Financial Update

Clinical Trial Data Announc...

Delisting Notice

Update of Presentation

Delisting Notice

Financial Results

Financial Results

Financial Results

Financial Results and Manag...

Appointment of Director

Exclusive License Agreement...

Delisting Notice

External Links:

On December 12, 2025, Alan Holmer announced his resignation from Corbus Pharmaceuticals' Board, effective December 31, 2025, due to retirement, with no disagreements related to the company.

AI Assistant

CORBUS PHARMACEUTICALS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.